Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342
Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.
Share
Why It Matters
A stock expert thinks Tenet Healthcare is a good company to watch. They raised their price guess to show they believe in it more.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.